Institute of Precision Medicine, College of Medicine, National Sun Yat-sen University, Kaohsiung, Taiwan; School of Medicine, College of Medicine, National Sun Yat-sen University, Kaohsiung, Taiwan.
Institute of Precision Medicine, College of Medicine, National Sun Yat-sen University, Kaohsiung, Taiwan.
Mol Cell Proteomics. 2024 May;23(5):100768. doi: 10.1016/j.mcpro.2024.100768. Epub 2024 Apr 15.
Mass spectrometry (MS)-based single-cell proteomics (SCP) provides us the opportunity to unbiasedly explore biological variability within cells without the limitation of antibody availability. This field is rapidly developed with the main focuses on instrument advancement, sample preparation refinement, and signal boosting methods; however, the optimal data processing and analysis are rarely investigated which holds an arduous challenge because of the high proportion of missing values and batch effect. Here, we introduced a quantification quality control to intensify the identification of differentially expressed proteins (DEPs) by considering both within and across SCP data. Combining quantification quality control with isobaric matching between runs (IMBR) and PSM-level normalization, an additional 12% and 19% of proteins and peptides, with more than 90% of proteins/peptides containing valid values, were quantified. Clearly, quantification quality control was able to reduce quantification variations and q-values with the more apparent cell type separations. In addition, we found that PSM-level normalization performed similar to other protein-level normalizations but kept the original data profiles without the additional requirement of data manipulation. In proof of concept of our refined pipeline, six uniquely identified DEPs exhibiting varied fold-changes and playing critical roles for melanoma and monocyte functionalities were selected for validation using immunoblotting. Five out of six validated DEPs showed an identical trend with the SCP dataset, emphasizing the feasibility of combining the IMBR, cell quality control, and PSM-level normalization in SCP analysis, which is beneficial for future SCP studies.
基于质谱(MS)的单细胞蛋白质组学(SCP)使我们有机会在不受抗体可用性限制的情况下,公正地探索细胞内的生物学变异性。该领域发展迅速,主要集中在仪器的进步、样品制备的改进和信号增强方法上;然而,由于高比例的缺失值和批次效应,很少对最佳数据处理和分析进行研究,这是一个艰巨的挑战。在这里,我们引入了一种定量质量控制方法,通过考虑 SCP 数据内部和跨数据的方法,来增强差异表达蛋白(DEPs)的鉴定。将定量质量控制与运行间等压标记匹配(IMBR)和 PSM 水平归一化相结合,额外定量了 12%和 19%的蛋白质和肽,其中超过 90%的蛋白质/肽含有有效值。显然,定量质量控制能够减少定量变化和 q 值,并能更明显地分离细胞类型。此外,我们发现 PSM 水平归一化与其他蛋白质水平归一化的性能相似,但保留了原始数据的分布,而无需额外的数据处理要求。在我们改进后的流程的概念验证中,选择了六个独特鉴定的 DEPs,它们表现出不同的倍数变化,并对黑色素瘤和单核细胞的功能起着关键作用,用于免疫印迹验证。六个验证的 DEPs 中有五个与 SCP 数据集的趋势相同,这强调了在 SCP 分析中结合 IMBR、细胞质量控制和 PSM 水平归一化的可行性,这对未来的 SCP 研究是有益的。